Complications of Untreated Pelvic Inflammatory Disease (PID)
Table of Contents
Pelvic Inflammatory Disease (PID) is an infection of the female reproductive organs, including the uterus, fallopian tubes, and ovaries. It typically results from sexually transmitted infections (STIs) like chlamydia and gonorrhea, though other infections can also cause PID. When PID is left untreated or inadequately treated, it can lead to a number of serious and long-term complications that can affect a woman’s reproductive health and overall well-being (Sharma & Chandola, 2012). This article explores the major complications associated with untreated PID.
1. Infertility
One of the most severe complications of untreated PID is infertility. PID can cause scarring and blockages in the fallopian tubes, preventing eggs from being fertilized or successfully implanted in the uterus. It is estimated that about 10-15% of women with untreated PID will become infertile (Singhal & Patel, 2020). The risk of infertility increases with each episode of PID, as the infection can cause cumulative damage to the reproductive organs (Tiwari, 2017).
2. Ectopic Pregnancy
PID increases the risk of ectopic pregnancy, a life-threatening condition where a fertilized egg implants outside the uterus, most commonly in the fallopian tube. The scarring caused by untreated PID makes it more difficult for the fertilized egg to move through the fallopian tubes, increasing the likelihood of the egg implanting in the wrong location. Ectopic pregnancies can cause severe abdominal pain, internal bleeding, and may require emergency surgery to prevent further complications (Lad, 2002).
3. Chronic Pelvic Pain
Women who do not receive treatment for PID may develop chronic pelvic pain due to ongoing inflammation and damage to the pelvic organs. This pain can persist for months or even years, significantly affecting a woman’s quality of life. The pain may be felt during menstruation, sexual intercourse, or physical activity. In many cases, the pain is caused by adhesions or scar tissue that forms as a result of repeated or untreated infections (Bhavsar et al., 2020).
4. Tubal-Ovarian Abscess
In severe cases of untreated PID, women may develop a tubal-ovarian abscess, which is a collection of pus that forms in the fallopian tubes or ovaries. These abscesses can rupture if not treated promptly, leading to life-threatening complications such as peritonitis (infection of the abdominal lining) and sepsis (a severe infection that spreads throughout the body) (Sharma & Chandola, 2012). Surgical drainage or removal of the abscess may be required to prevent further damage to the reproductive organs (Singhal & Patel, 2020).
5. Adhesions and Scarring
Untreated PID often leads to adhesions, which are bands of scar tissue that form between organs in the pelvic region. These adhesions can cause the pelvic organs to stick together, leading to distorted anatomy and impaired function. Scarring can block the fallopian tubes, affect the movement of eggs from the ovaries, and cause pain during sexual intercourse (Lad, 2002). Over time, these adhesions can worsen, complicating both reproductive health and general well-being.
6. Peritonitis and Sepsis
In some cases, untreated PID can lead to peritonitis, a severe infection of the tissue lining the abdominal wall (the peritoneum). This occurs when the infection spreads from the reproductive organs into the abdominal cavity. If not treated promptly, peritonitis can lead to sepsis, a life-threatening condition where the infection spreads throughout the bloodstream, causing organ failure and death (Tiwari, 2017). Sepsis is a medical emergency that requires immediate intervention with antibiotics and supportive care (Sharma & Chandola, 2012).
7. Recurrent PID
Women with untreated PID are at a significantly higher risk of experiencing recurrent episodes of the disease. Each subsequent infection can cause further damage to the reproductive organs, increasing the likelihood of complications such as infertility, chronic pelvic pain, and ectopic pregnancy. Recurrent PID also poses challenges in treatment, as repeated infections can lead to antibiotic resistance, making the condition more difficult to manage (Dash & Junius, 2012).
8. Complications During Pregnancy
If PID is left untreated, it can lead to complications during pregnancy, including miscarriage, preterm birth, and low birth weight. The scarring and inflammation caused by PID can interfere with a woman’s ability to carry a pregnancy to term, and untreated infections can increase the risk of intrauterine infections, which can negatively affect fetal development (Lad, 2002).
9. Emotional and Mental Health Impacts
Living with the complications of untreated PID, such as chronic pain, infertility, and the emotional toll of recurrent infections, can significantly impact a woman’s mental health. Many women experience anxiety, depression, and stress related to the long-term consequences of the disease, especially if fertility is affected or the condition disrupts intimate relationships (Bhavsar et al., 2020).
Preventing Complications
The best way to prevent the complications of PID is through early detection and treatment. This includes:
- Timely Medical Attention: Seek medical help at the first signs of infection, such as unusual vaginal discharge, pelvic pain, or irregular menstrual bleeding.
- Regular STI Testing: Women who are sexually active should get regularly tested for STIs, particularly if they have multiple sexual partners.
- Antibiotic Treatment: Prompt treatment with antibiotics can prevent the infection from spreading and causing long-term damage. It is important to complete the full course of antibiotics, even if symptoms improve.
- Safe Sex Practices: Using condoms and limiting sexual partners can help reduce the risk of contracting STIs that lead to PID.
Conclusion
Pelvic Inflammatory Disease is a serious condition that can have lasting effects on a woman’s reproductive health if left untreated. The complications, ranging from infertility to life-threatening infections, highlight the importance of early detection and treatment. Regular check-ups, practicing safe sex, and paying attention to symptoms are essential steps in preventing the onset of PID and its long-term consequences (Tiwari, 2017).
References
1. Centers for Disease Control and Prevention. Sexually Transmitted Diseases. Pelvic Inflammatory Diseases. Statistics. Available from: https://www.cdcc.gov/std/pid/stats.html. [Last accessed on 2021 Mar 29].
2. Oosterwijk S. Choosing the negative:A behavioral demonstration of morbid curiosity. PLoS One 2017;12:e0178399.
3. Morris GC, Stewart CM, Schoeman SA, Wilson JD. A cross-sectional study showing differences in the clinical diagnosis of pelvic inflammatory disease according to the experience of clinicians:Implications for training and audit. Sex Transm Infect 2014;90:445–51.
4. Vanamala VG, Pakyanandhan S, Rachel A, Abraham P. Pelvic inflammatory disease and the risk factors. Int J Reprod Contracept Obstet Gynecol 2018;7:3572–5.
5. Acharya YT. Acharya Agnivesha, Charak Smahita, Elaborated by Acharya Charak and Dridhabala. Varanasi: Chaukhambha Prakashan; 2013. 635.
6. Acharya YT. Acharya Sushruta, Sushruta Samhita, Elaborated by Dalhana Acharya and Gayadasa Acharya. Varanasi: Chaukhambha Surabharati Prakashana; 2014. 639.
7. Shashtri A. Bhaishajya Ratnavali of Bhishak Shree Govindadas, Shotharoga Chikitsa 42/135. Varanasi: Chaukhambha Sanskrit Sansthan; 2014. 803.
8. Acharya YT. Acharya Agnivesha, Charak Smahita, Elaborated by Acharya Charak and Dridhabala. Varanasi: Chaukhambha Prakashan; 2013. 639.
9. Kulkarni SK. Handbook of Experimental Pharmacology. Delhi: Vallabh Prakashana; 2003. 128–31.
10. Kumar K, Saideepthi V, Shaik S, Nandini M, Suthakaran R. Evaluation of analgesics potential of Boerhavia diffusa roots in albino mice. Res J Pharmacogn Phytochem 2017;9:111–4.
11. Sharma M, Vohra S, Arnason JT, Hudson JB. Extracts contain significant and selective activities against human pathogenic bacteria. Pharm Biol 2008;46:111–6.
12. Pandeya G. Bhavaprakasha Nighantu of Acharya Bhavamishra. Varanasi: Chaukhambha Orientalia; 2010. 508.
13. Chaudhary G, Dantu P. Morphological, phytochemical and pharmacological, studies on Boerhavia diffusa L. J Med Plan Res 2011;5:2125–30.
14. Gour R. Boerhaavia Diffusa Linn Plant:A Review –One Plant with Many Therapeutic Use. Int J Pharm Sci Med 2021;6:25–41.
15. Hiruma-Lima CA, Gracioso JS, Bighetti EJ, Germonsén Robineou L, Souza Brito AR. The juice of fresh leaves of Boerhaavia diffusa L. (Nyctaginaceae) markedly reduces pain in mice. J Ethnopharmacol 2000;71:267–74.
16. Kirtikar KR, Basu BD. Boerhaavia diffusa. Indian Medicinal Plants. Allahabad, India: Lalit Mohan Basu Publications; 1956. 2045–8.
17. Wagh S, Vidhale NN. Antimicrobial Efficacy of Boerhaavia Diffusa against some human pathogenic bacteria and fungi. Biosci Biotechnol Res Asia 2010;7:267–72.
18. Bisht A, Jain S, Misra A, Dwivedi J, Paliwal S, Sharma S. Cedrus deodara (Roxb. ex D. Don) G. Don:A review of traditional use, phytochemical composition and pharmacology. J Ethnopharmacol 2021;279:114361.
19. Singh SS, Pandey SC, Srivastava S, Gupta VS, Patro B, Ghosh AC. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J Pharmacol 2003;35:83–91.
20. Rawat N, Roushan R. Guduchi:A potential drug in Ayurveda. World J Pharm Res 2018;7:355–61.
21. Singh D, Singh D, Choi S, Zo S, Byul KS, Han S. Therapeutical effect of extracts of Tchebula in inhibiting human pathogens and free radical. Int J Biosci Biochem Bioinform 2012;2:164–7.
22. Verma S, Jain A, Gupta VB. Synergistic and sustained anti-inflammatory activity of guggul with the ibuprofen:A preliminary study. Int J Pharm Biosci 2010;1:1–7.
23. Vats S, Miglani K. Synergistic antimicrobial effect of cow urine and Azadirachta indica on infectious microbes. Int J Pharm Sci Res 2011;2:1781–5.
24. Gupta S, Gabrani R, Ali J, Dang S. Exploring novel approaches to vaginal drug delivery. Recent Pat Drug Deliv Formul 2011;5:82–94.
25. Alok S, Ratendra K, Udai VS, Ramandeep S. Development of quality control parameters for the standardization of stem bark of Ficus benghalensis Linn. J Acute Dis 2013;2:296–9.
26. Malairajan P, Gopalkrishan G, Narasimhan S, Kavimani S. Antiulcer activity of ficus glomerata. Pharm Biol 2007;45:674–7.
27. Singh B, Chaudhary LC, Agarwal N, Kamra DN. Effect of feeding ficus infectoria leaves on rumen microbial profile and nutrient utilization in goats. Asian Aust J Anim Sci 2011;24:810–7.
28. Roy K, Shivakumar H, Sarkar S. Wound healing potential of leaf extracts of Ficus religiosa on wistar albino strain rats. Int J Pharm Tech Res 2009;1:506–8.
29. Vasudevan M, Gunnam KK, Parle M. Antinociceptive and anti-inflammatory effects of Thespesia populnea bark extract. J Ethnopharmacol 2007;109:264–70.
30. Patankar G, Grampurohit ND. Detection of phytoconstituent responsible for anti-microbial activity Panchavalkal. Aryavaidyan 1999;12:221–5.
